FeesSafety
Pluang+

Labcorp partners with FDA and Charles River to improve drug abuse potential assessment for safer medicines.

Market News
22 Oct 2026, 23:30 WIB
PRNewsWire
View Source
Bullish
Labcorp partners with FDA and Charles River to improve drug abuse potential assessment for safer medicines.

Labcorp has announced a collaboration with the U.S. FDA and Charles River Laboratories to enhance the scientific methods used to evaluate the abuse potential of new medicines. This partnership combines Labcorp's experience in regulatory abuse studies with FDA's data analysis expertise to develop better tools for predicting how medicines might be misused. The goal is to support safer drug development and improve regulatory decisions, ultimately protecting patients and communities from drug abuse risks. This collaboration also leverages Labcorp's toxicology capabilities to monitor emerging drug threats and trends.

Labcorp's collaboration with the FDA and Charles River to advance preclinical drug abuse evaluation methods is presented here with Pluang's Health sector market data as of Oct 23, 2026 03:21 WIB. Among 150 priced US Health-sector stocks tradable on Pluang, 84 rose and 66 fell. Notable movers include Davita Inc (DVA) at USD 186.56 with a 5.51% increase, Biogen Inc (BIIB) at USD 253.82 up 5.33%, and DENTSPLY SIRONA Inc (XRAY) at USD 9.50 rising 4.63%.

More News

Space42 posts 11% revenue growth and 30% EBITDA rise in 9M 2026, driven by strong government contracts and AI solutions.

Space42 posts 11% revenue growth and 30% EBITDA rise in 9M 2026, driven by strong government contracts and AI solutions.

Space42 reported an 11% increase in revenues to USD 404 million and a 30% rise in normalized EBITDA to USD 194 million for the first nine months of 2026. Growth was driven by strong performances in both Space Services, boosted by a major government c...

Company Fundamentals
Bullish
39 minutes ago
YYForce projects 22% revenue growth to $70M for fiscal 2026, driven by AI workforce platform demand.

YYForce projects 22% revenue growth to $70M for fiscal 2026, driven by AI workforce platform demand.

YYForce Inc. forecasts revenue of $70 million for fiscal year 2026, marking a 22% increase from $57.2 million in 2025. This growth is attributed to rising demand for its AI-driven Workforce OS platform, expanded robotics deployments, and increased re...

Company Fundamentals
Bullish
1 hour ago
YYForce projects 22% revenue growth to $70M for fiscal 2026, driven by AI and robotics demand.

YYForce projects 22% revenue growth to $70M for fiscal 2026, driven by AI and robotics demand.

YYForce Inc. has issued a revenue guidance of $70 million for the fiscal year ending December 31, 2026, representing an approximate 22% increase from the audited $57.2 million revenue in fiscal 2025. This growth is attributed to rising demand for its...

Company Fundamentals
Bullish
1 hour ago
YYForce projects 22% revenue growth to $70M for fiscal 2026, driven by AI workforce and robotics demand.

YYForce projects 22% revenue growth to $70M for fiscal 2026, driven by AI workforce and robotics demand.

YYForce Inc. forecasts its fiscal 2026 revenue to reach $70 million, a 22% increase from the audited $57.2 million in fiscal 2025. This growth is attributed to rising demand for its AI-based workforce management platform, increased adoption of commer...

Company Fundamentals
Bullish
1 hour ago
YYForce projects 22% revenue growth to $70M in 2026, driven by AI and robotics demand in Southeast Asia.

YYForce projects 22% revenue growth to $70M in 2026, driven by AI and robotics demand in Southeast Asia.

YYForce Inc. forecasts revenue of $70 million for fiscal year 2026, marking a 22% increase from $57.2 million in 2025. This growth is fueled by rising demand for its AI-powered Workforce OS platform, commercial robotics, and recurring software and se...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App